The MarketReader Minute
💊 Intellia Plunges After HAE Therapy Results, While Zai Lab Rises on Lung Cancer Data and Viking Therapeutics Soars on Obesity Drug Optimism | Biotech Sector Insights
(IBB) has seen a decline of 0.2% since Wednesday. Key contributors to this performance included IQV, which dropped significantly. Moderna Inc. experienced a modest decline and received a price target reduction from UBS, while Piper Sandler maintained an Overweight rating.